Literature DB >> 14528516

Factors associated with body function and disability in patients with ankylosing spondylitis: a cross-sectional study.

Albrecht Falkenbach1, Annegret Franke, Sjef van der Linden.   

Abstract

OBJECTIVE: To determine for patients with ankylosing spondylitis (AS) which factors are associated with disability and restricted body function.
METHODS: In 1538 patients with AS, occiput-to-wall distance, chest expansion, cervical rotation, finger-floor distance, and modified Schober test were measured cross-sectionally, and for each measure the patient's respective percentile was calculated. The mean of the 5 percentiles was summarized in the mobility restriction score (MRS). In addition, patients answered questions on disease progression and completed the Bath AS Functional Index (BASFI) questionnaire. All data were coded into 40 variables, used as independent variables in multiple regression analyses to identify factors associated with BASFI and MRS.
RESULTS: Finger-to-floor distance (beta positive, +), cervical rotation (-), time since first AS symptoms (-), age (+), height loss (+), maximum height (-), delay in diagnosis (+), hip replacement (+), regular practice of sports (-), chest expansion (-), sex (worse BASFI in females), exposure to cold and dampness (+), and regular participation in AS group physical exercises (+) were significantly associated with worse BASFI. Significantly associated factors for worse MRS were height loss (+), sex (higher MRS in males), active inflammation of the cervical region (+), age (+), maximum height (-), active inflammation of the hip region (+), involvement of shoulders (+), time since first AS symptoms (+), urethritis (-), regular practice of sports (-), involvement of feet (-), and hip replacement (+). The models explain 47% of the variance observed for both the BASFI and MRS.
CONCLUSION: The amount of variance explained for both BASFI and MRS is rather high. The results apply primarily to groups of patients, but are insufficient to guide clinical decisions in individual patients. These findings contribute to our understanding of factors influencing disability and restriction in body function in AS.

Entities:  

Mesh:

Year:  2003        PMID: 14528516

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  9 in total

1.  Risk factors for poor hip flexion after total hip arthroplasty for the treatment of ankylosing spondylitis a multivariate analysis.

Authors:  Liang Zhang; Dejin Yang; Xinghua Yin; Yixin Zhou
Journal:  Clin Rheumatol       Date:  2014-03-21       Impact factor: 2.980

2.  Risk factors for functional limitations in patients with long-standing ankylosing spondylitis.

Authors:  Michael M Ward; Michael H Weisman; John C Davis; John D Reveille
Journal:  Arthritis Rheum       Date:  2005-10-15

3.  Assessment of shoulder involvement and disability in patients with ankylosing spondylitis.

Authors:  Emel Eksioglu; Ajda Bal; Berna Gulec; Ece Aydog; Aytul Cakci
Journal:  Rheumatol Int       Date:  2006-08-25       Impact factor: 2.631

4.  Functional limitations due to axial and peripheral joint impairments in patients with ankylosing spondylitis: are focused measures more informative?

Authors:  Siddharth Bethi; Abhijit Dasgupta; Michael H Weisman; Thomas J Learch; Lianne S Gensler; John C Davis; John D Reveille; Michael M Ward
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-04       Impact factor: 4.794

5.  Regional radiographic damage and functional limitations in patients with ankylosing spondylitis: differences in early and late disease.

Authors:  Michael M Ward; Thomas J Learch; Lianne S Gensler; John C Davis; John D Reveille; Michael H Weisman
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-02       Impact factor: 4.794

6.  [Physiotherapeutic and rehabilitation therapy for ankylosing spondylitis. Status quo and are they still necessary in the age of anti-cytokine therapy?].

Authors:  U Lange; B Kürten; U Müller-Ladner; C Uhlemann
Journal:  Z Rheumatol       Date:  2007-12       Impact factor: 1.372

7.  Association of macroscopic gut inflammation with disease activity, functional status and quality of life in ankylosing spondylitis.

Authors:  Gulen Hascelik; Bengi Oz; Nese Olmez; Asuman Memis; Gazi Yoruk; Belkis Unsal; Nese Ekinci
Journal:  Rheumatol Int       Date:  2008-11-22       Impact factor: 2.631

8.  Factors influencing health status and disability of patients with ankylosing spondylitis in the Czech Republic.

Authors:  S Forejtová; H Mann; J Stolfa; K Vedral; I Fenclová; D Némethová; K Pavelka
Journal:  Clin Rheumatol       Date:  2008-02-05       Impact factor: 2.980

9.  Both baseline clinical factors and genetic polymorphisms influence the development of severe functional status in ankylosing spondylitis.

Authors:  Ruxandra Schiotis; Nerea Bartolomé; Alejandra Sánchez; Magdalena Szczypiorska; Jesús Sanz; Eduardo Cuende; Eduardo Collantes Estevez; Antonio Martínez; Diego Tejedor; Marta Artieda; Anca Buzoianu; Juan Mulero
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.